Champions Oncology Reports Record Quarterly Revenue of $5.2 Million

Friday, December 8, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

Quarterly operating profit driven by double-digit revenue growth

Condensed Consolidated Statements of Cash Flows (Unaudited)

Six Months EndedOctober 31,

2017

2016

Cash flows from operating activities:

Net Loss

$

(768)

$

(3,051)

Adjustments to reconcile net cash used in operations:

Stock-based compensation expense

711

1,664

Issuance of common stock for services

30

15

Depreciation and amortization expense

132

87

Allowance for doubtful accounts

(41)

(2)

Changes in operating assets and liabilities

(1,745)

(1,268)

Net cash used in operating activities

(1,681)

(2,555)

Cash flows from investing activities:

Purchases of property and equipment

(942)

(30)

Net cash used in investing activities:

(942)

(30)

Cash flows from financing activities:

Public Offering June 2016, net of financing costs of $742,000

4,340

Capital lease payments

(12)

(12)

Net cash (used in) provided by financing activities:

(12)

4,328

Increase (decrease) in cash and cash equivalents

(2,635)

1,743

Cash and cash equivalents, beginning of period

3,295

2,585

Cash and cash equivalents, end of period

$

660

$

4,328



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store